Microbot Medical Inc.

NASDAQ:MBOT

Medical - Instruments & Supplies

Healthcare
$0.98 -2.93%

-$0.06 today

Market cap
$65.73M
Beta
1.04
P/E (TTM)
-8.6
EPS (TTM)
-$0.21
52W Low $1.60High $4.67

Volume 0.87M

Average 1.60M

MBOT Free Cash Flow

Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.

Microbot Medical Inc.NASDAQ: MBOT

Free Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Free cash flow growth accelerates

Q1 FY2026 free cash flow of $5.16M (cash outflow) rose 78.8% year over year, ahead of the +65.3% change in trailing-twelve-month free cash flow. Sequentially, it rose 36.4% from the prior quarter. Over 3 fiscal years it compounded at +4.1% a year.

Context

  • Free cash flow grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +78.8% holds above the trailing-twelve-month pace of +65.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$5.16M+36.4% QoQ
Last fiscal yearDec 2025
-$13.11M+48.1% YoY
LTMMar 2026
-$15.38M+65.3% YoY
Free Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+78.8%——
1 year+48.1%——
3-year CAGR+4.1%——
5-year CAGR——
10-year CAGR——

Free Cash Flow history

USD · from the cash flow

Latest · FY2025
(13.11M) USD
Year-over-year change
-48.1%

Free Cash Flow vs competitors

How MBOT compares with its peers on the latest reported figures

  • Peers report in different currencies, so free cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +65.3% is the 2nd highest of 10, against a peer median of -6.0%.
  • Free cash flow amounts to 14647.6% of revenue for MBOT, versus a peer median of 3280.3%.
MBOT Competitors
Free Cash Flow for MBOT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DCGODocGo Inc.LTM Mar 2026$5.09T USD-6032961.8%+4.9%1686400.7%
OVIDOvid Therapeutics Inc.LTM Mar 2026$41.95M USD-15.4%-12.2%589.1%
CNTXContext Therapeutics Inc.LTM Mar 2026$32.82M USD+115.0%+23.3%—
RCELAVITA Medical, Inc.LTM Mar 2026$30.75M USD-34.2%+18.9%42.5%
VANIVivani Medical, Inc.LTM Mar 2026$26.52M USD+21.6%+10.1%—
CRDLCardiol Therapeutics Inc.LTM Mar 2026CA$24.3M CAD-4.0%-4.4%—
CLNNClene Inc.LTM Mar 2026$18.1M USD-6.0%-25.1%13509.0%
MBOTMicrobot Medical Inc.LTM Mar 2026$15.38M USD+65.3%+4.1%14647.6%
ORMPOramed Pharmaceuticals Inc.LTM Mar 2026$8.74M USD-16.5%-27.6%—
ZTEKZentek Ltd.LTM Mar 2026CA$5.45M CAD+0.4%-30.6%3280.3%
Peer median (excluding MBOT) —-6.0%-4.4%3280.3%

Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(11.31M)(13.17M)(10.74M)(11.44M)(13.14M)
Depreciation & Amortization76K102K106K91K47K
Deferred Income Tax00000
Stock-Based Compensation1.39M1.75M1.39M1.35M1.06M
Change in Working Capital497K(228K)(11K)942K(1.01M)
Accounts Receivables00000
Inventory0000(584K)
Accounts Payables00000
Other Working Capital497K(228K)(11K)942K(424K)
Other Non-Cash Items1.39M(7K)718K234K0
Operating Cash Flow(9.35M)(11.55M)(8.53M)(8.83M)(13.05M)
Capital Expenditures(69K)(84K)(33K)(25K)(60K)
Acquisitions (Net)00000
Purchases of Investments0(3.75M)(10.06M)(5.12M)(82.93M)
Sales of Investments3.27M012.06M6.68M10.6M
Other Investing Activities0(3K)3K00
Investing Cash Flow3.2M(3.84M)1.97M1.54M(72.38M)
Debt Repayment00000
Common Stock Issued04.32M6.56M7.94M86.24M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities00000
Financing Cash Flow04.32M6.56M7.94M86.24M
Effect of Forex Changes00000
Net Change in Cash(6.15M)(11.06M)(2K)646K810K
Free Cash Flow(9.42M)(11.63M)(8.57M)(8.85M)(13.11M)

Microbot Medical Inc.

NASDAQ:MBOT

Intrinsic Alpha fair value

Locked

Current Price

$0.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.